Effect of the glucagon-like peptide-1 receptor agonist exenatide on bone status in obese, non-diabetic, antipsychotic-treated schizophrenia spectrum patients

Robert Eriksson; Brian Villumsen Broberg; Pelle Lau Ishøy; Nikolaj Bak; Ulrik B Andersen; Niklas R Jorgensen; Filip Krag Knop; Bjørn Ebdrup

doi:10.1093/schbul/sbz021.268

Effect of the glucagon-like peptide-1 receptor agonist exenatide on bone status in obese, non-diabetic, antipsychotic-treated schizophrenia spectrum patients

Robert Eriksson, Brian Villumsen Broberg, Pelle Lau Ishøy, Nikolaj Bak, Ulrik B Andersen, Niklas R Jorgensen, Filip Krag Knop, Bjørn Ebdrup

Steno Diabetes Center Copenhagen

Original language	English
Article number	O12.4
Journal	Schizophrenia Bulletin
Volume	45
Issue number	Suppl 2
Pages (from-to)	198
Number of pages	1
ISSN	0586-7614
DOIs	https://doi.org/10.1093/schbul/sbz021.268
Publication status	Published - Apr 2019
Event	Congress of the Schizophrenia International Research Society 2019: Schizophrenia Conference - Orlando, United States Duration: 10 Apr 2019 → 14 Apr 2019

Conference

Conference	Congress of the Schizophrenia International Research Society 2019
Country/Territory	United States
City	Orlando
Period	10/04/2019 → 14/04/2019

Access to Document

10.1093/schbul/sbz021.268

Cite this

Eriksson, R., Broberg, B. V., Ishøy, P. L., Bak, N., Andersen, U. B., Jorgensen, N. R., Knop, F. K., & Ebdrup, B. (2019). Effect of the glucagon-like peptide-1 receptor agonist exenatide on bone status in obese, non-diabetic, antipsychotic-treated schizophrenia spectrum patients. Schizophrenia Bulletin, 45(Suppl 2), 198. Article O12.4. https://doi.org/10.1093/schbul/sbz021.268

Effect of the glucagon-like peptide-1 receptor agonist exenatide on bone status in obese, non-diabetic, antipsychotic-treated schizophrenia spectrum patients. / Eriksson, Robert; Broberg, Brian Villumsen ; Ishøy, Pelle Lau et al.
In: Schizophrenia Bulletin, Vol. 45, No. Suppl 2, O12.4, 04.2019, p. 198.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

@article{16a45b0a10e647feb0402d9e348a5230,

title = "Effect of the glucagon-like peptide-1 receptor agonist exenatide on bone status in obese, non-diabetic, antipsychotic-treated schizophrenia spectrum patients",

author = "Robert Eriksson and Broberg, \{Brian Villumsen\} and Ish{\o}y, \{Pelle Lau\} and Nikolaj Bak and Andersen, \{Ulrik B\} and Jorgensen, \{Niklas R\} and Knop, \{Filip Krag\} and Bj{\o}rn Ebdrup",

year = "2019",

month = apr,

doi = "10.1093/schbul/sbz021.268",

language = "English",

volume = "45",

pages = "198",

journal = "Schizophrenia Bulletin",

issn = "0586-7614",

publisher = "Oxford University Press",

number = "Suppl 2",

note = "Congress of the Schizophrenia International Research Society 2019 : Schizophrenia Conference, SRIS ; Conference date: 10-04-2019 Through 14-04-2019",

}

TY - ABST

T1 - Effect of the glucagon-like peptide-1 receptor agonist exenatide on bone status in obese, non-diabetic, antipsychotic-treated schizophrenia spectrum patients

AU - Eriksson, Robert

AU - Broberg, Brian Villumsen

AU - Ishøy, Pelle Lau

AU - Bak, Nikolaj

AU - Andersen, Ulrik B

AU - Jorgensen, Niklas R

AU - Knop, Filip Krag

AU - Ebdrup, Bjørn

PY - 2019/4

Y1 - 2019/4

U2 - 10.1093/schbul/sbz021.268

DO - 10.1093/schbul/sbz021.268

M3 - Conference abstract in journal

SN - 0586-7614

VL - 45

SP - 198

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

IS - Suppl 2

M1 - O12.4

T2 - Congress of the Schizophrenia International Research Society 2019

Y2 - 10 April 2019 through 14 April 2019

ER -